Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
Nicholas George Nickols, Sonny Tsai, Nathanael Kane, Silvia V. Diaz-Perez et autres
163 Background: Treatment paradigms for oligometastatic castration-sensitive prostate cancer patients are evolving. Molecular imaging improves staging, intensified systemic and primary tumor directed therapy improves survival, metastasis-directed therapy improves local control. The impact of combining these imaging and therapeutic approaches into a planned …
us (code pays fourni par la source)
1 citation
Journal of Clinical Oncology